
The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)
The United States Food and Drug Administration has approved Copiktra™ (duvelisib). The drug is now approved as a treatment for adult patients diagnosed with refractory or relapsed chronic lymphocytic leukaemia…